(searched for: 10.29328/journal.jcavi.1001007)
Published: 26 April 2021
Journal of Child, Adult Vaccines and Immunology, Volume 5, pp 001-008; https://doi.org/10.29328/journal.jcavi.1001007
Related COVID vaccine production many different strategies was followed by the producers. Observing some rare event of thrombosis after some COVID-19 vaccination, it is interesting to verify if the Target used for the manufacturing can be involved in a different procoagulant activity or not. Some vaccine are suspended in some country or under a deep new verify- investigation by the regulatory agency. (EU or USA). This fact it is relevant. The target SPIKE-PROTEIN FULL LENGTH modified or not or towards the RBD domain can be a relevant factor.